Guillain-Barré syndrome.
Li
Hai-Feng
HF
Xie
Yan-Chen
YC
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D004334:Drug Administration Schedule; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors; D017063:Outcome Assessment, Health Care / Q000379:methods; D010956:Plasmapheresis / Q000592:standards; D016032:Randomized Controlled Trials as Topic / Q000379:methods* / Q000592:standards
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D018836:Inflammation Mediators